Current Report Filing (8-k)
December 05 2022 - 4:32PM
Edgar (US Regulatory)
0000816956
false
0000816956
2022-12-05
2022-12-05
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15 (d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported):
December 5, 2022
CONMED CORPORATION
(Exact name of registrant as specified in its
charter)
Delaware |
001-39218 |
16-0977505 |
(State or other jurisdiction of |
(Commission File Number) |
(I.R.S. Employer |
incorporation or organization) |
|
Identification No.) |
11311 Concept Blvd
Largo, Florida 33773
(Address of principal executive offices, including
zip code)
(727) 392-6464
(Registrant's telephone number, including area
code)
Check the appropriate box below if the Form 8-K filing is intended
to simultaneously satisfy the filing obligations of the registrant under any of the following provisions (See General Instruction
A.2 below):
| ☐ | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| ☐ | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| ☐ | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| ☐ | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities registered pursuant to Rule 12(b)
of the Act
Title of each class |
Trading Symbol(s) |
Name of
each exchange on which registered |
Common Stock, $0.01 par value |
CNMD |
NYSE |
Indicate by check mark whether the registrant is an emerging growth
company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange
Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant
has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided
pursuant to Section 13(a) of the Exchange Act. ☐
Item 8.01 Other Events
On December 5, 2022, CONMED Corporation announced
it will be paying a quarterly cash dividend of $0.20 per share on January 5, 2023 to all shareholders of record as of December 16, 2022.
Signature
Pursuant to the requirements of the Securities Exchange
Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
|
|
Date: December 5, 2022 |
CONMED CORPORATION |
|
(Registrant) |
|
|
|
|
|
|
|
By: |
/s/ Todd W. Garner |
|
Name: |
Todd W. Garner |
|
Title: |
Executive Vice President- |
|
|
Chief Financial Officer |
CONMED (NYSE:CNMD)
Historical Stock Chart
From May 2024 to Jun 2024
CONMED (NYSE:CNMD)
Historical Stock Chart
From Jun 2023 to Jun 2024